Company intelligence / Profile preview

ArtVentive Medical Group

San Marcos, California, United Statesartventivemedical.com ↗

Ownership: Private
Development stage: Other

Overview

ArtVentive Medical Group has developed and commercialized the EOS Plug, a minimally invasive endoluminal occlusion device used in over 1,600 clinical cases with successful immediate vessel occlusion. The product is CE marked in Europe and FDA cleared in the US. Clinical data demonstrate safe, effective, and precise placement with reduced procedure time and radiation exposure.

Therapeutic areas: Cardiovascular
Modalities: Device (specifically, vascular embolization plug)
Industry: Implantable Medical Devices

Partnerships

International distribution partners in Europe, Israel, Australia, New Zealand; preparing to enter Latin America; interest from Asia-Pacific regions including Korea, Japan, Vietnam, China, India, Singapore

Beyond the preview

Go deeper on ArtVentive Medical Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ArtVentive Medical Group.

Explore the full profile